SCHEMBL16257513

SCHEMBL16257513

COc1ccc2ccc(Nc3ncnc(C(=O)O)c3C)cc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.45
MAPT P10636 1/20 0.43
GRM1 Q13255 1/20 0.43
AKR1C3 P42330 2/20 0.43
AKR1C2 P52895 2/20 0.43
HTT P42858 2/20 0.42
MEN1 O00255 1/20 0.42
PKM P14618 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
SHMT2 P34897 1/20 0.42
EGFR P00533 5/20 0.42
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42
RAB9A P51151 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KDM4E B2RXH2 1/20 0.42
NCOA1 Q15788 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
KDR P35968 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16257609 0.98 CSF1R (0.47) CSF1RMAPTGRM1AKR1C3AKR1C2
SCHEMBL16257512 0.87 EGFR (0.48) MAPTMEN1KMT2ASHMT2EGFR
SCHEMBL16257589 0.87 CSNK2A2 (0.48) MAPTMEN1MAPK1KMT2AEGFR
SCHEMBL16257591 0.84 EGFR (0.50) MAPTHTTMEN1KMT2ASHMT2
SCHEMBL16257514 0.82 KDM4E (0.46) MAPK1EGFRKDM4E
SCHEMBL12180012 0.82 CCR2 (0.48) NPC1ALDH1A1RAB9ASYK
SCHEMBL12180017 0.79 CCR2 (0.49) MEN1MAPK1KMT2AALDH1A1SYK
SCHEMBL16257576 0.76 ANO1 (0.49) EGFRKDRTNIK
SCHEMBL15033668 0.75 KMO (0.58) HTTMEN1KMT2AEGFRNPC1
SCHEMBL16257511 0.74 DHODH (0.55) MAPTEGFRNPC1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946218-B2 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-02-03 US disclosed
EP-2569295-B1 NEW CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed